TNXP Stock Analysis: Buy, Sell, or Hold?
TNXP - Tonix Pharmaceuticals Holding Corp.
$12.34
-0.10 (-0.80%)
▼
5d:
+3.01%
30d:
+5.29%
90d:
-9.8%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When TNXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called TNXP this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TNXP shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: TNXP shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: TNXP is currently trading at $12.34, which is considered slightly high relative to its 30-day fair value range of $11.38 to $12.58.
Technical Outlook: Technically, TNXP is in a strong downtrend. Immediate support is located at $10.87, while resistance sits at $13.04.
Market Sentiment: TNXP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.20 (+242.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TNXP is in a strong downtrend. Immediate support is located at $10.87, while resistance sits at $13.04.
Market Sentiment: TNXP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.20 (+242.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$11.38 -
$12.58
Company Quality Score
57/100
(HOLD)
Options IV Signal
33th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- NEUTRAL: Options fairly priced (IV 33th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 242.0% below Wall St target ($42.20)
Trading Range Analysis
30-Day Trading Range
$11.38 -
$12.58
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$2.27
(18.4%)
Support & Resistance Levels
Support Level
$10.87
Resistance Level
$13.04
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.58
Wall Street Target
$42.20
(+242.0%)
Revenue Growth (YoY)
183.2%
Share & Embed Analysis
Last updated: July 04, 2026 5:45 AM ET
Data refreshes hourly during market hours. Next update: 6:45 AM
Data refreshes hourly during market hours. Next update: 6:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNXP showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Seth Lederman
BUY
15000 shares
2026-03-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 56 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 61 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 62 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 61 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 57 HOLD |
